A randomized trial of bortezomib in late antibody-mediated kidney transplant rejection

F Eskandary, H Regele, L Baumann… - Journal of the …, 2018 - journals.lww.com
Late antibody-mediated rejection (ABMR) is a leading cause of kidney allograft failure.
Uncontrolled studies have suggested efficacy of the proteasome inhibitor bortezomib, but no …
被引用次数：284 相关文章

[引用][C] A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection

F Eskandary, H Regele, L Baumann, G Bond… - Journal of the American …, 2017 - cir.nii.ac.jp
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.

F Eskandary, H Regele, L Baumann… - Journal of the …, 2017 - europepmc.org
Late antibody-mediated rejection (ABMR) is a leading cause of kidney allograft failure.
Uncontrolled studies have suggested efficacy of the proteasome inhibitor bortezomib, but no …

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection

F Eskandary, H Regele, L Baumann, G Bond… - 2018 - pubmed.ncbi.nlm.nih.gov
Late antibody-mediated rejection (ABMR) is a leading cause of kidney allograft failure.
Uncontrolled studies have suggested efficacy of the proteasome inhibitor bortezomib, but no …
[HTML] nih.gov

[HTML][HTML] A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection

F Eskandary, H Regele, L Baumann… - Journal of the …, 2018 - ncbi.nlm.nih.gov
Late antibody-mediated rejection (ABMR) is a leading cause of kidney allograft failure.
Uncontrolled studies have suggested efficacy of the proteasome inhibitor bortezomib, but no …
[PDF] academia.edu

[PDF][PDF] A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection

F Eskandary, H Regele, L Baumann… - Journal of the …, 2018 - academia.edu
Late antibody-mediated rejection (ABMR) is a leading cause of kidney allograft failure.
Uncontrolled studies have suggested efficacy of the proteasome inhibitor bortezomib, but no …
[PDF] academia.edu

[PDF][PDF] A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection

F Eskandary, H Regele, L Baumann… - Journal of the …, 2018 - academia.edu
Late antibody-mediated rejection (ABMR) is a leading cause of kidney allograft failure.
Uncontrolled studies have suggested efficacy of the proteasome inhibitor bortezomib, but no …

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.

F Eskandary, H Regele, L Baumann… - Journal of the …, 2017 - europepmc.org
Late antibody-mediated rejection (ABMR) is a leading cause of kidney allograft failure.
Uncontrolled studies have suggested efficacy of the proteasome inhibitor bortezomib, but no …